A seasoned business development professional with a deep understanding of Early Clinical Drug Development interested in networking with customers in the pharmaceutical, biotech, device and animal health sectors in need of Bioanalytical, Preclinical, and Clinical Pharmacology services.
KCAS: non-GLP and GLP PK/PD method development, validation, and sample analysis. Immunogenicity assays, Neutralizing Antibody Assays, Alkaline Hematin (endpoint marker for blood loss, like menorrhagia), protein binding assessment, scheduled compounds, radioactive compounds, Clinical PK Sample Collection Kits, Biorepository services.
Platforms: LC-MS/MS, ELISA, RIA, ECL (MSD Sector Imager 6000), HPLC.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
